National Health Service
Richmond House
79 Whitehall
London
SW1A 2NS
United Kingdom
Tel: 44-207-210-4850
Fax: 44-207-270-5244
40 articles with National Health Service
-
Scientists from the U.K. may have identified several more environmental causes for cancer after evaluating genetic data of over 12,000 cancer patients from the NHS files.
-
NHS Study Demonstrates Eko Smart Stethoscope Can Identify Heart Failure
2/1/2022
Eko announced that the Imperial College of London, in conjunction with the UK National Health Service, published a study1 which highlights Eko's ability to screen patients for heart failure in seconds with AI during physical exams.
-
The CMA said some pharmaceutical firms charge the NHS with excessively high prices for hydrocortisone tablets and paid off potential competitors to stay out of the market.
-
Paige, Oxford University and UK NHS Partners Win Government Funding to Evaluate Paige Prostate Cancer Detection System
6/21/2021
Paige, a global leader in AI-based diagnostic software in pathology, announced that the Company, Oxford University and National Health Service regional partners in the United Kingdom have won the prestigious Phase 4 Artificial Intelligence in Health and Care award from the NHS Accelerated Access Collaborative to study Paige Prostate prospectively in a real-world cancer laboratory setting.
-
INSIGHTEC Announces MR-guided Focused Ultrasound to Treat Essential Tremor Received Funding by National Health Service (NHS) England
11/24/2020
INSIGHTEC®, a global healthcare company focused on the therapeutic power of acoustic energy, announced that the National Health Service England has approved funding for MR-guided Focused Ultrasound for the treatment of medication-refractory Essential Tremor patients from April 2021.
-
Successful Elocta Bid Means Increased Access for People With Haemophilia A in the UK
6/26/2020
Through an agreement with National Health Service and SobiTM, people living with haemophilia A in the United Kingdom will have increased access to Elocta following a successful bid in the United Kingdom's haemophilia A tender.
-
electroCore, Inc. Announces Extension of NHS England’s Innovation and Technology Payment (ITP) Program to Fund Continued Use of gammaCore™ in the U.K.ITP program reimbursing for gammaCore™ extended to Sept. 30, 2020
4/8/2020
electroCore, Inc. announced that England’s National Health Service has exercised its option to extend the Innovation and Technology Payment Program for the use of gammaCore in the treatment of cluster headache in adults.
-
NICE Recommends the Use of gammaCore for the Treatment of Cluster Headache in the NHS
12/3/2019
NICE has today published a medical technologies guidance document recommending the use of gammaCore within the NHS for the acute and preventive treatment of cluster headache in the U.K.
-
NHS England will acquire hepatitis C drugs from the companies at competitive prices and work to identify patients around the country.
-
Nearly 8,000 Packets of Orkambi Destroyed as the U.K. and Vertex Hash out Pricing Concerns
3/28/2019
Cystic fibrosis drugmaker Vertex was forced to destroy nearly 8,000 packs of its drug Orkambi after the medication had expired before they could be shipped to the United Kingdom due to a contentious pricing fight. -
Sensyne Health, a London-based healthcare artificial intelligence (AI) company founded by biotech entrepreneur Paul Drayson, recently launched an initial public offering (IPO) on the London AIM market. Drayson’s plan is to raise $78 million. It’s just one of many companies that are exploiting adv...
-
Health Education England and St. George's University Reach Agreement on New Programme to Fill Postgraduate Medical Training Programmes in England
7/12/2018
Leaders of Health Education England (HEE), part of the National Health Service (NHS), and St George's University (SGU) signed a Memorandum of Understanding to enable SGU School of Medicine graduates to undertake postgraduate training in England, with the first intake expected in the autumn of 2018.
-
Alexion Reaches Funding Agreement With NICE And National Health Service England For Strensiq (Asfotase Alfa) For Patients With Pediatric-Onset Hypophosphatasia (HPP)
7/5/2017
-
Encouraging Early Results Of Major 10,000 Patient National Health Service Lung Cancer Screening Trial Using EarlyCDT-Lung Blood Test Announced At The 16th World Conference On Lung Cancer
9/8/2015
-
National Health Service Awards Significant Cytogenetics Tender To Oxford Gene Technology Ltd.
2/4/2014
-
Alimera Sciences Ships First ILUVIEN® Orders For U.K. National Health Service Hospitals
1/13/2014
-
Science Reveals the Best Time to Drink Coffee, National Health Service Study
11/12/2013
-
National Health Service Hit for Millions by Overcharging "Scam"
7/16/2013
-
The Royal Liverpool University Hospital Becomes First National Health Service Facility in England to Achieve the Highest Level of Accreditation for "First in Human" Clinical Trials
6/27/2013
-
NHS Scotland Chooses Carestream Health, Inc. Technology for Breast Cancer Screening
3/28/2013